Elanco Animal Health Incorporated

NYSE:ELAN Stok Raporu

Piyasa değeri: US$6.6b

Elanco Animal Health Yönetim

Yönetim kriter kontrolleri 3/4

Elanco Animal Health CEO'su Jeff Simmons, Jul2018 tarihinde atandı, in görev süresi 6.33 yıldır. in toplam yıllık tazminatı $ 13.66M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.8% maaş ve 91.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.23% ine doğrudan sahiptir ve bu hisseler $ 14.92M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.9 yıl ve 5.7 yıldır.

Anahtar bilgiler

Jeff Simmons

İcra Kurulu Başkanı

US$13.7m

Toplam tazminat

CEO maaş yüzdesi8.8%
CEO görev süresi6.3yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresi5.9yrs
Yönetim Kurulu ortalama görev süresi5.7yrs

Son yönetim güncellemeleri

Recent updates

Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Nov 15
Elanco Animal Health's (NYSE:ELAN) Solid Profits Have Weak Fundamentals

Elanco Animal Health: Not Expensive, But Debt Remains An Issue

Nov 08

Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Sep 22
Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Sep 01
Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Elanco Animal Health: Positioned For Success

Aug 16

Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Jul 11
Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Elanco Animal Health: Pipeline Concerns Appear Overblown

Jun 30

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Jun 06
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Animal Health: At Least Fully Valued After Rally

Jun 05

Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Apr 22
Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Feb 24
Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Elanco Animal Health: A Solid Sale Addresses Leverage

Feb 09

Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 01
Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Elanco Animal Health: Turning More Healthy

Dec 21

Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Nov 09
Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile

Oct 05

Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Aug 02
Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Elanco Animal Health: Seems Like A Decent Bet Right Now

Jul 25

Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges

Jul 14

There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Jun 09
There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Feb 22
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Q4 2022 Earnings Preview

Feb 20

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Nov 08
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Q3 2022 Earnings Preview

Nov 07

Elanco Animal Health: This 'Sick Dog' Should Recover

Oct 19

CEO Tazminat Analizi

Jeff Simmons'un ücretlendirmesi Elanco Animal Health'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

US$205m

Jun 30 2024n/an/a

-US$1b

Mar 31 2024n/an/a

-US$1b

Dec 31 2023US$14mUS$1m

-US$1b

Sep 30 2023n/an/a

-US$1b

Jun 30 2023n/an/a

-US$113m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$13mUS$1m

-US$78m

Sep 30 2022n/an/a

-US$132m

Jun 30 2022n/an/a

-US$171m

Mar 31 2022n/an/a

-US$371m

Dec 31 2021US$12mUS$1m

-US$483m

Sep 30 2021n/an/a

-US$698m

Jun 30 2021n/an/a

-US$729m

Mar 31 2021n/an/a

-US$572m

Dec 31 2020US$9mUS$1m

-US$574m

Sep 30 2020n/an/a

-US$246m

Jun 30 2020n/an/a

-US$101m

Mar 31 2020n/an/a

-US$13m

Dec 31 2019US$16mUS$1m

US$68m

Sep 30 2019n/an/a

US$94m

Jun 30 2019n/an/a

US$144m

Mar 31 2019n/an/a

US$45m

Dec 31 2018US$5mUS$775k

US$87m

Sep 30 2018n/an/a

-US$91m

Jun 30 2018n/an/a

-US$172m

Mar 31 2018n/an/a

-US$174m

Dec 31 2017US$5mUS$688k

-US$311m

Tazminat ve Piyasa: Jeff 'nin toplam tazminatı ($USD 13.66M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 7.94M ).

Tazminat ve Kazançlar: Jeff 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Jeff Simmons (57 yo)

6.3yrs

Görev süresi

US$13,663,169

Tazminat

Mr. Jeffrey N. Simmons, also known as Jeff, serves as President and Chief Executive Officer at Elanco Animal Health Incorporated since July 2018 and its Director since September 2018. Mr. Simmons serves as...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jeffrey Simmons
President6.3yrsUS$13.66m0.23%
$ 14.9m
Todd Young
Executive VP & CFO6yrsUS$3.73m0.035%
$ 2.3m
Ramiro Cabral
Executive Vice President of Elanco International6.3yrsUS$2.65m0.022%
$ 1.5m
Ellen de Brabander
Executive Vice President of Research3.1yrsUS$3.68m0.0097%
$ 635.6k
Timothy Bettington
Executive Vice President of Corporate Strategy & Market Development1.7yrsUS$2.19m0.017%
$ 1.1m
James Meer
Senior VP & Chief Accounting Officer6.2yrsVeri yok0.0054%
$ 357.9k
Chris Keeley
Senior VP & Chief Information Officerno dataVeri yokVeri yok
David Kinard
Executive Vice President of Human Resources5.8yrsUS$2.85m0.024%
$ 1.5m
Katy Grissom
Head of Investor Relationsno dataVeri yokVeri yok
Shiv O'Neill
Executive Vice President1.8yrsVeri yok0.0048%
$ 316.5k
Larbi Lier
Senior Vice President of Asiano dataVeri yokVeri yok
Shabbir Simjee
Chief Medical Officerno dataVeri yokVeri yok

5.9yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: ELAN 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.9 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jeffrey Simmons
President6.2yrsUS$13.66m0.23%
$ 14.9m
William Doyle
Independent Director3.9yrsUS$330.01k0.0061%
$ 399.4k
Roy Hoover
Independent Director6.2yrsUS$496.01k0.060%
$ 3.9m
Paul Herendeen
Independent Director3.9yrsUS$330.01k0.0020%
$ 132.9k
Lawrence Kurzius
Independent Chairman6.2yrsUS$350.01k0.0020%
$ 132.9k
Art Garcia
Independent Director5.5yrsUS$330.01k0.00071%
$ 46.7k
Denise Scots-Knight
Independent Director5.7yrsUS$330.01kVeri yok
John Paul Bilbrey
Independent Director5.7yrsUS$346.01k0.0084%
$ 555.3k
Deborah Kochevar
Independent Director5.7yrsUS$346.01k0.00020%
$ 13.2k
Kirk McDonald
Independent Director5.7yrsUS$330.01kVeri yok
Michael Harrington
Independent Director6.2yrsUS$330.01k0.0040%
$ 260.6k
Kapila Anand
Independent Director6.2yrsUS$355.01k0.00065%
$ 42.8k

5.7yrs

Ortalama Görev Süresi

65.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ELAN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.7 yıldır).